What is the clinical and cost effectiveness of catheter-based intravascular blood pumps, such as Impella, for heart failure, cardiogenic shock, acute coronary syndrome, or during high-risk percutaneous coronary intervention?
No direct evidence for the clinical and cost-effectiveness of Impella for heart failure, cardiogenic shock, or acute coronary syndrome was identified. Available studies highlight potential benefits and significant risks, emphasizing the need for further research.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-10-26
- DOI
- https://doi.org/10.5281/zenodo.23665200
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.00